Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00QOJ
|
|||
| Former ID |
DIB009930
|
|||
| Drug Name |
99mTc-RP-128
|
|||
| Synonyms |
(SP-5-25)-Hydrogen [N,N-dimethylglycyl-kappaN-L-seryl-kappaN-L-cysteinyl-kappaN,kappaS-glycyl-L-threonyl-L-lysyl-L-prolyl-L-prolyl-L-argininato(4-)]oxotechnetate(1-)-99Tc; 186037-48-9
Click to Show/Hide
|
|||
| Indication | Diagnostic imaging [ICD-11: N.A.] | Phase 2 | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tuftsin receptor (TR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Evaluation of 99mTc-RP128 as a potential inflammation imaging agent: human dosimetry and first clinical results. J Nucl Med. 2001 Jan;42(1):154-61. | |||
| REF 2 | WO patent application no. 2013,1850,32, Nanotherapeutics for drug targeting. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.